Pfizer Inc (NYSE:PFE)
| 51.49 Delayed Data As of Jun 24 |  +1.40 / +2.79%Today’s Change | 38.82 Today|||52-Week Range 61.71 | -12.80% Year-to-Date |
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 50.09 |
| Today’s open | 50.59 |
| Day’s range | 50.32 - 51.65 |
| Volume | 24,343,179 |
| Average volume (3 months) | 27,258,629 |
| Market cap | $289.5B |
Data as of 5:58pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +128.42% |
| Earnings growth (this year) | +52.39% |
| Earnings growth (next 5 years) | -2.70% |
| Revenue growth (last year) | +93.97% |
| P/E ratio | 11.6 |
| Price/Sales | 4.15 |
| Price/Book | 3.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +12.92 | +4.13% |
| ABBVAbbVie | +3.17 | +2.12% |
| MRKMerck | +1.33 | +1.45% |
| AZNAstraZeneca | +2.32 | +3.60% |
Data as of 4:22pm ET, 06/24/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $1.82 |
| Annual revenue (last year) | $81.3B |
| Annual profit (last year) | $22.1B |
| Net profit margin | 27.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
